/ Not yet recruiting临床1期IIT A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Eltrombopag 25 mg tablets relative to Revolade 25 mg tablets in healthy Thai volunteers under fasting condition.
/ Not yet recruiting临床1期IIT A Bioequivalence study of a randomized, single dose, two-way crossover design with two-period, two-treatment and two-sequence of EMPAGLINAZ 25 (Empagliflozin Tablets 25 mg) relative to JARDIANCE film-coated tablets 25 mg in healthy Thai adult volunteers under fasting condition
/ Not yet recruiting临床1期IIT A Bioequivalence study of a randomized, single dose, two-way crossover design with two-period, two-treatment and two-sequence of AUROLENA 5 (Linagliptin Tablets 5 mg) relative toTRAJENTA film-coated tablets 5 mg in healthy Thai adult volunteers under fasting condition
100 项与 Bio-innova Co., Ltd 相关的临床结果
0 项与 Bio-innova Co., Ltd 相关的专利（医药）
100 项与 Bio-innova Co., Ltd 相关的药物交易
100 项与 Bio-innova Co., Ltd 相关的转化医学
